1. (a) APRNs may delegate access to the Prescription Drug Monitoring Program for running requested reports.

2. (b) APRNs with prescriptive authority shall review the report from the program prior to prescribing:

   1. (1) An opioid from Schedule II or Schedule III every time prescribing the medication to a patient;
   2. (2) A benzodiazepine medication for the first time and every six (6) months thereafter prescribing for a patient; and
   3. (3) A stimulant from Schedule II for the first time and every six (6) months thereafter prescribing for a patient.
3. (c) Review of the program report shall be documented in the patient’s medical record.

4. (d) Mandatory checking of the program does not apply when prescribing a controlled substance to a patient:

   1. (1) Immediately before or during surgery;
   2. (2) During recovery from surgery while in a healthcare facility;
   3. (3) In a healthcare facility;

   4. (4) When necessary to treat a patient in an emergency situation:

      1. (A) At the scene of an emergency;
      2. (B) In a licensed ground ambulance or air ambulance; or
      3. (C) In the intensive care unit of a licensed hospital;
   5. (5) In palliative care or hospice;
   6. (6) In a licensed nursing home facility; or
   7. (7) In situations in which the program is not accessible due to technological or electrical failure.

Codification Notes: “APRN” means advanced practice registered nurse.